ARCHIVES

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

This article is from The Cancer Letter archive.

Vol. 37 No. 15 | April 15, 2011

Download PDF Visit The Full Archive

Related Articles

Alan Rabson Named Acting NCI Director

October 5, 2001

In Brief: Cancer Series Helps Do In Woodward As Post Metro Editor; OCC RFP Canceled, to Reappear As 4-5 RFPs

January 15, 1982

House Bill Provides 5.7% Increase To NIH, But Passage Threatened By Amendments

August 4, 1995

Human Protein Index Stirs NCI, NCAB Interest, Fires Up Growing Controversy

August 7, 1981

UC Davis Study Finds Patients Need Practical Information

June 28, 2002

In Brief: Gift to Jefferson Funds Capizzi Professorship; Abrams Named Special Assistant to DDES

January 9, 1998